CA
NZ
UK
AU
IND
US
Atossa (NASDAQ:ATOS) Therapeutics used an AACR rare-cancers conference in Vancouver to present preclinical data suggesting its lead drug, (Z)-endoxifen, may address a rare pediatric endocrine disorder called McCune-Albright Syndrome, alongside its core breast-cancer and Duchenne muscular dystrophy programs. The pitch is a single molecule …
Azitra, Inc. (NYSEAMERICAN:AZTR) has told shareholders it is redirecting capital from its slower rare-disease trial toward a cosmetic filaggrin ingredient and licensed recombinant-protein tools, betting on shorter paths to revenue. The shift follows fresh financing, a going-concern warning, two reverse splits and an ongoing …
Banzai (NASDAQ:BNZI) International closed its acquisition of ConnectAndSell on July 2, 2026, adding a higher-margin AI sales platform that, combined on a pro forma basis with Banzai's own 2025 results, roughly doubles annual revenue. The deal arrives alongside a going-concern warning, two reverse stock …
Beamr Imaging Ltd. (NASDAQ:BMR), an Israeli video-compression specialist whose technology already serves Netflix and Paramount, is redirecting its patented compression engine toward autonomous-vehicle data pipelines. The strategic pivot is real and well-documented in SEC filings, but the company's core business remains tiny, revenue has …
BioAtla (NASDAQ:BCAB) built its pipeline around Conditionally Active Biologics designed to spare healthy tissue while attacking tumors. In 2026 the San Diego biotech gutted its workforce by roughly 70%, hired an advisor to explore a sale of assets, and disclosed substantial doubt about its …
BioStem Technologies, Inc. (OTC:BSEM) closed out a pivotal stretch in early July 2026, winning four new U.S. design patents for its placental allograft technology and filing a Form 10 registration statement with the SEC. The Pompano Beach, Florida regenerative-medicine company is chasing a Nasdaq …
Bit (NASDAQ:BTBT) Digital has recast itself from a bitcoin miner into an Ethereum treasury and staking company that also controls roughly 70% of Nasdaq-listed AI infrastructure operator WhiteFiber. With 162,080.6 ETH reported as of May 31, 2026, and a new loan facility funding WhiteFiber's …
Blaize Holdings, Inc. (NASDAQ:BZAI), an edge-AI chipmaker that went public through a 2025 merger with blank-check company BurTech Acquisition Corp, reported first-quarter 2026 revenue of just $2.7 million even as it touts partnerships with Nokia, Winmate and NeoTensr. Gross margin improved sharply and losses …
Boston Scientific Corporation (NYSE:BSX) has agreed to buy thrombectomy specialist Penumbra in a cash-and-stock deal valued at roughly $14.5 billion in enterprise value. The transaction, awaiting Penumbra shareholder approval and customary closing conditions, would add scaled clot-removal technology to a cardiovascular business already growing …
BTC Digital Ltd. (NASDAQ:BTCT), a Cayman Islands-incorporated bitcoin miner, closed a private placement on June 29, 2026 that delivered roughly $7 million upfront and up to $28 million if warrants are exercised. The cash will jump-start an 8-megawatt AI computing buildout in Georgia, a …
Please wait processing your request...